A review of cancer immunotherapy toxicity.

Kennedy, Lucy Boyce; Salama, April K S

Kennedy, Lucy Boyce; Salama, April K S.

Afiliación

Kennedy LB; Hematology/Oncology, Duke University, Durham, North Carolina.
Salama AKS; Division of Medical Oncology, Duke University, Durham, North Carolina.

CA Cancer J Clin ; 70(2): 86-104, 2020 03.

Article en En | MEDLINE | ID: mdl-31944278

Asunto(s)

Factores Inmunológicos/uso terapéutico; Inmunoterapia/métodos; Neoplasias/terapia; Humanos

Palabras clave

checkpoint inhibitor; chimeric antigen receptor (CAR) T cells; cytokine release syndrome; cytotoxic T-lymphocyte antigen 4 (CTLA-4); immune effector cell-associated neurotoxicity syndrome (ICANS); immune-related adverse events (irAEs); programmed cell death protein 1 (PD-1)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores Inmunológicos / Inmunoterapia / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: CA Cancer J Clin Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google